Editas Medicine Inc - Company Profile
Powered by 
All the sales intelligence you need on Editas Medicine Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Editas Medicine Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Editas Medicine Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Editas Medicine Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US11834649B2 | Grant | Crispr/cas-related methods and compositions for treating herpes simplex virus | C12N15/102; C12N15/1133; C12N2310/10; C12N2310/20; C12N2800/80; C12N9/22 | December 05, 2023 |
| AU2017305404B2 | Grant | Compositions and methods for treating cep290 associated disease | C12N15/11; C12N15/113; C12N15/86; C12N15/907; C12N2310/20; C12N2320/32; C12N2330/50; C12N2330/51; C12N2750/14143; C12N2800/80; C12N9/22; A61K35/761; A61K9/0048 | November 30, 2023 |
| WO2023220206A2 | Application | Genome editing of b cells | November 16, 2023 | |
| WO2023220207A2 | Application | Genome editing of cells | November 16, 2023 | |
| US20230365980A1 | Application | Methods for improving crispr/cas-mediated genome-editing | C12N15/102; C12N15/64; C12N2310/122; C12N2310/20; C12N9/1241 | November 16, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer